In randomized managed trials, There's two treatment options currently regarded the regular of care in Guillain-Barré syndrome (GBS). These include possibly intravenous immunoglobulin (IVIG) or plasma exchange. IVIG is https://ksnr.org.in/guillain-barre-syndrome/